{"entity":{"type":"insider","cik":"0001646300","url":"/insider/0001646300","json_url":"/insider/0001646300.json","name":"Trachtenberg Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2016-05-18","last":"2024-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Trachtenberg Eric","source":"filing","n_filings":10,"first_seen":"2016-05-18","last_seen":"2024-01-05"}],"transactions":[{"id":2521764,"accession":"0001415889-24-000772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000772","line_url":"/filing/0001415889-24-000772#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1227.0,"shares_display":"1,227","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":8269.98,"total_display":"8,269.98","total_whole":"8,270","shares_owned_after":68066.0,"shares_owned_after_display":"68,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8383079,"accession":"0001415889-23-000640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000640","line_url":"/filing/0001415889-23-000640#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60.0,"shares_display":"60","price_per_share":28.55,"price_display":"28.55","price_state":"stated","total_value":1713.0,"total_display":"1,713.00","total_whole":"1,713","shares_owned_after":11495.0,"shares_owned_after_display":"11,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6666213,"accession":"0001415889-22-010882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010882","line_url":"/filing/0001415889-22-010882#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194.0,"shares_display":"194","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":1264.88,"total_display":"1,264.88","total_whole":"1,265","shares_owned_after":2030.0,"shares_owned_after_display":"2,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6724506,"accession":"0001415889-22-007063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-007063","line_url":"/filing/0001415889-22-007063#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2613.0,"shares_display":"2,613","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":966.81,"total_display":"966.81","total_whole":"967","shares_owned_after":111203.0,"shares_owned_after_display":"111,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6363214,"accession":"0001415889-22-000401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000401","line_url":"/filing/0001415889-22-000401#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":3705.0,"total_display":"3,705.00","total_whole":"3,705","shares_owned_after":113816.0,"shares_owned_after_display":"113,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4398250,"accession":"0001415889-21-005013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005013","line_url":"/filing/0001415889-21-005013#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9449.0,"shares_display":"9,449","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":17008.2,"total_display":"17,008.20","total_whole":"17,008","shares_owned_after":116666.0,"shares_owned_after_display":"116,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4446225,"accession":"0001415889-21-003260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003260","line_url":"/filing/0001415889-21-003260#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2452.0,"shares_display":"2,452","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":14148.04,"total_display":"14,148.04","total_whole":"14,148","shares_owned_after":126115.0,"shares_owned_after_display":"126,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":6572143,"accession":"0001104659-18-019365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-019365","line_url":"/filing/0001104659-18-019365#line-1","is_derivative":false,"issuer_cik":"0001646300","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001646300","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer (GC, CCO & Secretary)","role_mark":"O","role_mark_label":"Officer (GC, CCO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC, CCO & Secretary","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3471.0,"shares_display":"3,471","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":5900.7,"total_display":"5,900.70","total_whole":"5,901","shares_owned_after":198093.0,"shares_owned_after_display":"198,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":4108205,"accession":"0001104659-17-041339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-041339","line_url":"/filing/0001104659-17-041339#line-1","is_derivative":false,"issuer_cik":"0001646300","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001646300","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer (GC, CCO & Secretary)","role_mark":"O","role_mark_label":"Officer (GC, CCO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC, CCO & Secretary","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7720.0,"shares_display":"7,720","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":10267.6,"total_display":"10,267.60","total_whole":"10,268","shares_owned_after":201564.0,"shares_owned_after_display":"201,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-23","filed_date":"2017-06-23","scope":"insider"},{"id":3243015,"accession":"0001104659-16-121878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-121878","line_url":"/filing/0001104659-16-121878#line-1","is_derivative":false,"issuer_cik":"0001646300","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001646300","owner_cik":"0001646300","owner_name":"Trachtenberg Eric","owner_display_name":"Trachtenberg Eric","owner_url":"/insider/0001646300","role":"Officer (GC, CCO & Secretary)","role_mark":"O","role_mark_label":"Officer (GC, CCO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC, CCO & Secretary","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.757,"price_display":"3.76","price_state":"stated","total_value":37570.0,"total_display":"37,570.00","total_whole":"37,570","shares_owned_after":144500.0,"shares_owned_after_display":"144,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"KALA BIO, Inc.","url":"/issuer/0001479419","role":"Officer","n_filings":7,"first_seen":"2021-06-29","last_seen":"2024-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Officer (GC, CCO & Secretary)","n_filings":3,"first_seen":"2016-05-18","last_seen":"2018-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001646300","retrieved_at":"2026-08-24T16:44:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}